THERIOPHARM

Entreprises (Petites et Moyennes Entreprises, Industrie)

www.linkedin.com/in/dr-ing-raphaël-duval-2763a4153Wavre, Belgique
3 visites de profil

Détails

  • nanomedicine platforms

  • drug deliverys systems

  • molecular encapsulation

  • drug repurposing

  • drug combination

  • prebiotics

Domaines d'activité

Maladies infectieuses, préparation et innovation antimicrobienne

1. HORIZON HLTH 2027 01 DISEASE 05 – Novel small molecule antivirals for epidemic pathogens4. HORIZON HLTH 2027 01 DISEASE 08 – Innovative antimicrobials against resistant pathogens

Médecine de précision et personnalisée

2. HORIZON HLTH 2027 02 DISEASE 01 two stage – Innovative healthcare interventions for non communicable diseases3. HORIZON HLTH 2027 01 DISEASE 10 – Prevention and management of chronic non communicable diseases in children and youth (GACD)4. HORIZON MISS 2027 02 CANCER 01 – Functional genomics to reveal novel targets for cancer treatment5. HORIZON MISS 2027 02 CANCER 02 – Clinical research by Comprehensive Cancer Infrastructures

Représentants

CEO

THERIOPHARM